Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bornhäuser

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Blood Cancer Journal|September 19, 2015
Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blastsR Aliperta, M Cartellieri, A Feldmann, et al.
Transfusion|March 10, 2001
Spleen enlargement in healthy donors during G-CSF mobilization of PBPCsU Platzbecker, G Prange-Krex, M Bornhäuser, et al.
Bone Marrow Transplantation|August 10, 2000
Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantationO Ringdén, M Remberger, V Runde, et al.
European Journal of Cancer Care|November 4, 2015
Feasibility of an exercise programme in elderly patients undergoing allogeneic stem cell transplantation - a pilot studyM K Schuler, B Hornemann, C Pawandenat, et al.
British Journal of Haematology|February 24, 2005
Activity of sirolimus in patients with myelodysplastic syndrome--results of a pilot studyU Platzbecker, M Haase, R Herbst, et al.
Blood|July 9, 1999
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantationO Ringdén, M Remberger, V Runde, et al.
Leukemia|February 17, 2006
Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemiaU Platzbecker, C Thiede, M Füssel, et al.
Bone Marrow Transplantation|January 13, 2004
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysisJ Schetelig, M Bornhäuser, M Kiehl, et al.
Annals of Hematology|March 22, 2002
Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphomaM Hänel, N Kröger, S Sonnenberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMTC Koenecke, B Hertenstein, J Schetelig, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Blood Cancer Journal|September 19, 2015
Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blastsR Aliperta, M Cartellieri, A Feldmann, et al.
Transfusion|March 10, 2001
Spleen enlargement in healthy donors during G-CSF mobilization of PBPCsU Platzbecker, G Prange-Krex, M Bornhäuser, et al.
Bone Marrow Transplantation|August 10, 2000
Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantationO Ringdén, M Remberger, V Runde, et al.
European Journal of Cancer Care|November 4, 2015
Feasibility of an exercise programme in elderly patients undergoing allogeneic stem cell transplantation - a pilot studyM K Schuler, B Hornemann, C Pawandenat, et al.
British Journal of Haematology|February 24, 2005
Activity of sirolimus in patients with myelodysplastic syndrome--results of a pilot studyU Platzbecker, M Haase, R Herbst, et al.
Blood|July 9, 1999
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantationO Ringdén, M Remberger, V Runde, et al.
Leukemia|February 17, 2006
Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemiaU Platzbecker, C Thiede, M Füssel, et al.
Bone Marrow Transplantation|January 13, 2004
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysisJ Schetelig, M Bornhäuser, M Kiehl, et al.
Annals of Hematology|March 22, 2002
Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphomaM Hänel, N Kröger, S Sonnenberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMTC Koenecke, B Hertenstein, J Schetelig, et al.
Pageof 11